在胰腺腺癌中,KRAS驱动的瘤发生和KRAS驱动的治疗
Minh T Than1,2, Mark O'Hara1,2, Ben Z Stanger1,2
1Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Molecular cancer therapeutics
|August 9, 2024
概括
胰腺癌 (PDAC) 是由KRAS突变驱动的. 用新药向KRAS显示出治疗这种致命疾病和改善患者结果的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 胰腺管腺癌 (PDAC) 是癌症死亡的主要原因.
- KRAS突变在PDAC中普遍存在,并驱动瘤生长和进展.
- 激活KRAS促进了支持瘤的微环境和免疫抑制.
研究的目的:
- 审查KRAS在PDAC启动和进展中的作用.
- 讨论开发针对KRAS的药物.
- 探索PDAC中KRAS抑制的治疗策略.
主要方法:
- 关于PDAC病变发生的文献评论.
- 对KRAS信号通路 (MAPK,MYC) 的分析.
- 在临床前和临床研究中小分子KRAS抑制剂的概述.
主要成果:
- 在PDAC中,KRAS激活驱动细胞增殖,存活和免疫抑制.
- 此外,KRAS还通过Sonic hedgehog和TGFβ等因素促进了脱质形成和免疫逃避.
- 新兴的KRAS抑制剂在PDAC模型和早期试验中显示出有效性.
结论:
- 克拉斯在癌细胞内在和外在PDAC发育中起着关键作用.
- 准KRAS代表了PDAC的精密医学的重大进步.
- 需要进一步的研究和临床试验来优化针对KRAS的治疗方法.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


